Imugene Receives Substantial Capital Injection; Extends Cash Runway to End of 2025 in Support of Ongoing Trials

Investing.com Dec 23 17:10 ET

Imugene to Raise AU$46 Million in Convertible Notes, Warrants Issue

MT NewswiresDec 23 16:58 ET

Imugene to Receive A$11 Million R&D Tax Refund for FY23 | ASX:IMU, OTC:IUGNF

Proactive InvestorsDec 18 17:12 ET

6 ASX Shares Down 50%+ in 2024. Are They Cheap?

The Motley FoolDec 2 23:59 ET

Imugene Doses First Patient in Intratumoral Injection Group of Phase 1 Cancer Trial

MT NewswiresNov 10 20:42 ET

Five at Five AU: ASX to End Week on a High Note | ASX:IMU, OTC:IUGNF

Proactive InvestorsNov 7 23:31 ET